´ëÇÑÀÓ»ó¹Ì»ý¹°ÇÐȸ 2022³âµµ Á¦25Â÷ Çмú´ëȸ (2ÀÏÂ÷) : 2022-07-08±³À°ÀÏÀÚ : 2022-07-08
±³À°Àå¼Ò : ¼¿ï¿Ã¸²ÇÈÆÄÅ©ÅÚ
±³À°ÁÖÁ¦ :
2022³âµµ Á¦25Â÷ Çмú´ëȸ (2ÀÏÂ÷)ÁÖÃÖ±â°ü : ´ëÇÑÀÓ»ó¹Ì»ý¹°ÇÐȸ
´ã´çÀÚ : ÀÌÇѳª
¿¬¶ôó : 02-401-1570
À̸ÞÀÏ :
kscm.office@gmail.com ±³À°Á¾·ù : ³»°ú, Áø´Ü°Ë»çÀÇÇаú, º´¸®°ú¹Ì»ý¹°ÇÐ
Âü¼®¿¹»óÀοø : 250¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 14 ½Ã°£ 30ºÐ
¼¼ºÎ¼ö°·á : 250,000¿ø
ºñ°í Á¤È¸¿ø 10¸¸¿ø, ÁØȸ¿ø 5¸¸¿ø, Æò»ýȸ¿ø 10¸¸¿ø, ´Üüȸ¿ø 10¸¸¿ø, ºñȸ¿ø 25¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 07-08 ¿Ã¸²ÇǾÆȦ 07:30~08:10 ME1: Basics in Diagnosis of Fungal Infection À̹̰æ(Áß¾ÓÀÇ´ë)
ÈÞ½Ä 07-08 ¿Ã¸²ÇǾÆȦ 08:10~09:00 Break/exhibition ()
±³À°½Ã°£ 07-08 ¿Ã¸²ÇǾÆȦ 09:00~09:30 The Response to SARS-CoV-2 variants in Korea-Current perspectives ±èÀºÁø(Áúº´°ü¸®Ã»)
±³À°½Ã°£ 07-08 ¿Ã¸²ÇǾÆȦ 09:30~10:00 Response to the national policy on COVID-19 in a Laboratory ±è³²Èñ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 07-08 ¿Ã¸²ÇǾÆȦ 10:00~10:30 Debate on Hot Topics: Omicron, To be or Not to be Airborne? Chair: Hee ÀÌÇõ¹Î(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 07-08 ¿Ã¸²ÇǾÆȦ 10:30~11:00 Debate on Hot Topics: Omicron, To be or Not to be Airborne? Chair: Hee äÆò±Õ(¼¿ïÀÇ´ë)
ÈÞ½Ä 07-08 ¿Ã¸²ÇǾÆȦ 11:00~11:10 Break/exhibition ()
±³À°½Ã°£ 07-08 ¿Ã¸²ÇǾÆȦ 11:10~12:00 Immune response to SARS-CoV-2 Á¶³²Çõ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 07-08 ¿Ã¸²ÇǾÆȦ 12:00~13:00 Microbiology innovation with laboratory automation Ana María Cárdenas(Sr Director Global Medical Affairs Becton Dickinson and Company)
±³À°½Ã°£ 07-08 ¿Ã¸²ÇǾÆȦ 13:00~13:30 Dilemma: Report of inconclusive SARS-CoV-2 PCR ¼ºÈï¼·(¿ï»êÀÇ´ë)
±³À°½Ã°£ 07-08 ¿Ã¸²ÇǾÆȦ 13:30~14:00 Laboratory test for assumption of SARS-CoV-2 infectivity ±èÀ¯°æ(°æºÏÀÇ´ë)
±³À°½Ã°£ 07-08 ¿Ã¸²ÇǾÆȦ 14:00~14:30 Potential tests for monitoring clinical course of COVID-19 ¹ÚÁöÈ£(°Ç±¹ÀÇ´ë)
ÈÞ½Ä 07-08 ¿Ã¸²ÇǾÆȦ 14:30~14:50 Break/exhibition ()
±³À°½Ã°£ 07-08 ¿Ã¸²ÇǾÆȦ 14:50~15:20 Current diagnosis of Clostridioides difficile in Korea Á¤Çý¼±(ÀÌÈÀÇ´ë)
±³À°½Ã°£ 07-08 ¿Ã¸²ÇǾÆȦ 15:20~15:50 Further advances in syndromic tests for sexually-transmitted infection À¯Àοµ(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 07-08 ¿Ã¸²ÇǾÆȦ 15:50~16:20 Recent update on laboratory diagnosis of viral hepatitis Á¶ÁøÈñ(ÀÌ¿øÀÇ·áÀç´Ü)
±âŸ 07-08 ¿Ã¸²ÇǾÆȦ 16:20~17:00 Closing Ceremony / General Assembly ()
±³À°½Ã°£ 07-08 ¼¿ïȦ 07:30~08:10 ME2 : Laboratory Test for Diagnosis and Management of Tuberculosis ±èâ±â(¼¿ïÀÇ°úÇבּ¸¼Ò)
ÈÞ½Ä 07-08 ¼¿ïȦ 08:10~09:00 Break/exhibition ()
±³À°½Ã°£ 07-08 ¼¿ïȦ 09:00~10:00 Oral Presentation I È«¼º±Ù ½ÅÈñºÀ(Â÷ÀÇ´ë ¼øõÇâÀÇ´ë)
±³À°½Ã°£ 07-08 ¼¿ïȦ 10:00~11:00 Oral Presentation II ±èÇö¼ö ½Å¼ö(ÇѸ²ÀÇ´ë ¼¿ïÀÇ´ë)
ÈÞ½Ä 07-08 ¼¿ïȦ 11:00~11:10 Break/exhibition ()
±³À°½Ã°£ 07-08 ¿Ã¸²ÇǾÆȦ 11:10~12:00 Immune response to SARS-CoV-2 Á¶³²Çõ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 07-08 ¼¿ïȦ 12:00~13:00 Comparative diagnostic accuracy of POC assay for the molecular diagnosis of SARS-CoV-2 in the Point-of-Care and critical care settings Alexander Domnich(SanMartino Hospital Italy)
ÈÞ½Ä 07-08 ¼¿ïȦ 13:00~13:30 Current status and future perspectives of Kor-GLASS ½ÅÁ¾Èñ(Àü³²ÀÇ´ë)
±³À°½Ã°£ 07-08 ¼¿ïȦ 13:30~14:00 Changes in major AMR trends amidst the COVID-19 pandemic Á¤¼®ÈÆ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 07-08 ¼¿ïȦ 14:00~14:30 Emerging AMR identified through the Kor-GLASS ±èµµ±Õ(¿¬¼¼ÀÇ´ë)
ÈÞ½Ä 07-08 ¼¿ïȦ 14:30~14:50 Break/exhibition ()
±³À°½Ã°£ 07-08 ¼¿ïȦ 14:50~15:20 New technique of disinfection ÀÌÁö¿µ(¼¿ï¼º¸ðº´¿ø)
±³À°½Ã°£ 07-08 ¼¿ïȦ 15:20~15:50 Strategy of CPE infection control À̽¿Á(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 07-08 ¼¿ïȦ 15:50~16:20 Diagnosis and management of catheter-associated infection ¹ÚÁ¤¼ö(¼¿ïÀÇ´ë)
±âŸ 07-08 ¿Ã¸²ÇǾÆȦ 16:20~17:00 Closing Ceremony / General Assembly ()